Operating Lease, Right-of-Use Asset of Vincerx Pharma, Inc. from 31 Mar 2021 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Vincerx Pharma, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2021 to 31 Dec 2024.
  • Vincerx Pharma, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2024 was $0, a 100% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Vincerx Pharma, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $0 -$2,201,000 -100% 31 Dec 2024 10-K 27 Mar 2025 2024 FY
Q3 2024 $1,431,000 -$1,016,000 -42% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $1,693,000 -$994,000 -37% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $1,950,000 -$973,000 -33% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 $2,201,000 -$863,000 -28% 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q3 2023 $2,447,000 -$844,000 -26% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $2,687,000 -$827,000 -24% 30 Jun 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 $2,923,000 -$810,000 -22% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $3,064,000 -$885,000 -22% 31 Dec 2022 10-K 29 Mar 2024 2023 FY
Q3 2022 $3,291,000 -$878,000 -21% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $3,514,000 -$703,000 -17% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $3,733,000 +$361,000 +11% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $3,949,000 31 Dec 2021 10-K 28 Mar 2023 2022 FY
Q3 2021 $4,169,000 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 $4,217,000 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $3,372,000 31 Mar 2021 10-Q 17 May 2021 2021 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.